| Market Research A to Z | Company Profiles A to Z | Register | Contact Us |
| +44 (0) 203 086 8600 Call us on |
| Market | Report Title | Report Type | Country | Published | Price |
|---|---|---|---|---|---|
|
|
Algeria Pharmaceuticals and Healthcare Report Q3 2013 | Market Research |
Algeria |
22 May 2013 |
£856.71 |
Algerian authorities appear committed to healthcare development programme, the 2010-2014 tranche of which envisages the construction of more than 150 new hospitals and numerous other facilities. This ... |
Add to Wishlist |
|
|||
|
|
Argentina Pharmaceuticals and Healthcare Report Q3 2013 | Market Research |
Argentina |
22 May 2013 |
£856.71 |
High inflation has undermined foreign drugmakers' profitability in Argentina's pharmaceutical market. The potential currency devaluation will further erode the returns of foreign investment.<br ... |
Add to Wishlist |
|
|||
|
|
Zambia Pharmaceuticals and Healthcare Report Q3 2013 | Market Research |
Zambia |
22 May 2013 |
£856.71 |
Zambia has a strong economy thanks to its relative political stability and copper mining industry, but there are considerable gaps in its provision of healthcare services. With many specialist healthc... |
Add to Wishlist |
|
|||
|
|
Hong Kong Pharmaceuticals and Healthcare Report Q3 2013 | Market Research |
Hong Kong |
22 May 2013 |
£856.71 |
Hong Kong's attractiveness as a pharmaceutical market hinges largely on its ageing and affluent demographics, its proximity to China as well as the stable political and economic environment.<br ... |
Add to Wishlist |
|
|||
|
|
New Zealand Pharmaceuticals and Healthcare Report Q3 2013 | Market Research |
New Zealand |
22 May 2013 |
£856.71 |
Low growth potential in New Zealand's pharmaceutical market will attract risk-averse investors. However, we note that regulatory delays in funding new medicines will hinder patients' access to pharmac... |
Add to Wishlist |
|
|||
|
|
Taiwan Pharmaceuticals and Healthcare Report Q3 2013 | Market Research |
Taiwan |
22 May 2013 |
£856.71 |
Taiwan will continue to represent a modestly attractive proposition for drug manufactures. Our view is based on factors such as the maturity of its pharmaceutical market, government encouragement of g... |
Add to Wishlist |
|
|||
|
|
Wound Care in Hong Kong, China | Market Research |
Hong Kong |
17 May 2013 |
£600.00 |
Wound care in 2012 had a stronger and steady current value growth with 2% due to a wider range and more innovative products offered in the market. There were more innovative packaging changes covering... |
Add to Wishlist |
|
|||
|
|
Analgesics in Hong Kong, China | Market Research |
Hong Kong |
17 May 2013 |
£600.00 |
Mainland Chinese visitors and traders prefer to buy analgesics in bulk in Hong Kong since there is a high tax in mainland China. The depreciation of the Hong Kong dollar also spearheaded more spending... |
Add to Wishlist |
|
|||
|
|
China Health Food Industry Report, 2013 | Market Research |
China |
17 May 2013 |
£1,400.00 |
Health food arose in China in 1980s; after three decades of development, China health food industry has formed with the value of RMB100 billion. In 2012, the sales revenue of the health food industry ... |
Add to Wishlist |
|
|||
|
|
Healthcare Distribution and Services Industry in the US - PEST Framework Analysis | Market Research |
United States |
16 May 2013 |
£132.31 |
The Healthcare Distributors and Services industry includes all distributors and wholesalers of health care products, plus dialysis centers and lab testing services. Wholesale drug distributors include... |
Add to Wishlist |
|
|||
|
|
Medtronic Inc - SWOT Framework Analysis | Company Profile |
Global |
16 May 2013 |
£72.77 |
Medtronic, Inc., based in suburban Minneapolis, Minnesota, is the world's largest medical technology company and is a Fortune 500 company. The company is engaged in medical technology - alleviating pa... |
Add to Wishlist |
|
|||
|
|
Wound Care in Turkey | Market Research |
Turkey |
15 May 2013 |
£600.00 |
Wound care in Turkey increased in value by 1% in 2012, a rate of growth which was commensurate with the 1% current value CAGR recorded over the entire review period. This low value growth was the resu... |
Add to Wishlist |
|
|||
|
|
AcuFocus, Inc. - Medical Equipment - Deals and Alliances Profile | Company Profile |
Global |
15 May 2013 |
£165.39 |
AcuFocus, Inc. (AcuFocus) is an ophthalmic medical device company. Its flagship product, KAMRA inlay, is an intra-corneal inlay for the treatment of presbyopia (near vision loss). It is an implant ... |
Add to Wishlist |
|
|||
|
|
Antisense Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile | Company Profile |
Global |
15 May 2013 |
£165.39 |
Antisense Pharma GmbH (Antisense Pharma) is a biotechnology company. The company conducts research and develops innovative pharmaceutical products. The company focuses on the development of antisen... |
Add to Wishlist |
|
|||
|
|
Analgesics in Turkey | Market Research |
Turkey |
15 May 2013 |
£600.00 |
Analgesics in Turkey remained a small OTC category at the end of the review period as only a limited range of topical analgesics/anaesthetic were able to be sold in the country without a prescription.... |
Add to Wishlist |
|
|||
|
|
Healthcare IT Market: Global Forecasts to 2017 | Market Research |
Global |
15 May 2013 |
£3,076.21 |
The global healthcare IT market is suggested to have reached a value of around $40.4 billion by the end of 2012, and is forecast to grow to a total of $56.7 billion by 2017. This would suggest a CA... |
Add to Wishlist |
|
|||
|
|
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2013 | Market Research |
Ivory Coast |
15 May 2013 |
£856.71 |
The risks of investing in Côte d'Ivoire's pharmaceutical and healthcare industry are numerous. Politically, the country is in a fragile state, with concerns over security commonplace.Econo... |
Add to Wishlist |
|
|||
|
|
Croatia Pharmaceuticals and Healthcare Report Q3 2013 | Market Research |
Croatia |
15 May 2013 |
£856.71 |
Croatia's entrance into the EU will accelerate its economic liberalisation and the development of the country's private sector. It is also likely to bring about an influx of EU funding in modernising ... |
Add to Wishlist |
|
|||
|
|
Japan Pharmaceuticals and Healthcare Report Q3 2013 | Market Research |
Japan |
15 May 2013 |
£856.71 |
Japan remains the most attractive market in the Asia Pacific, due to the ageing and affluent population and strong regulatory conditions. In particular, we highlight that the slowing economy poses opp... |
Add to Wishlist |
|
|||
|
|
Pakistan Pharmaceuticals and Healthcare Report Q3 2013 | Market Research |
Pakistan |
15 May 2013 |
£856.71 |
Increased longevity in developed markets translates into an increased demand for aged care healthcare services and medicines. However, in emerging markets such as Pakistan, despite increased life expe... |
Add to Wishlist |
|
|||
Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.